21st Century Storm Chasers: Defining Macrophage Activation Syndrome

Arthritis and Rheumatology

Volumn 68, Issue 3, 2016, Pages 557-560

  Canna, Scott W ^a   Nigrovic, Peter A ^b,c  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CONSENSUS; DISEASE CLASSIFICATION; HUMAN; MACROPHAGE ACTIVATION SYNDROME; PRIORITY JOURNAL; REVIEW; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; CLASSIFICATION; COMPLICATION; JUVENILE RHEUMATOID ARTHRITIS;

ARTHRITIS, JUVENILE; HUMANS; MACROPHAGE ACTIVATION SYNDROME;

EID: 84963863787     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39329     Document Type: Review

References (15)

1. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al., Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013; 110: 3507-12.
2. Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al, on behalf of the Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol 2016; 68:566-76.
3. Weaver LK, Behrens EM., Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol 2014; 26: 562-9.
4. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al., Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.
5. Davi S, Consolaro A, Guseinova D, Pistorio A, Ruperto N, Martini A, et al., An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2011; 38: 764-8.
6. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al., HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31.
7. Davi S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, et al, on behalf of the Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66: 2871-80.
8. Minoia F, Davi S, Horne A, Demirkaya E, Bovis F, Li C, et al, on behalf of the Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014; 66: 3160-9.
9. Minoia F, Davi S, Horne A, Bovis F, Demirkaya E, Akikusa J, et al, Pediatric Rheumatology International Trials Organization, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Histiocyte Society. Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Rheumatol 2015; 42: 994-1001.
10. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, et al., Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368: 1509-18.
11. Cron RQ, Behrens EM, Shakoory B, Ramanan AV, Chatham WW., Does viral hemorrhagic fever represent reactive hemophagocytic syndrome? J Rheumatol 2015; 42: 1078-80.
12. Simon DW, Aneja R, Carcillo JA, Halstead ES., Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis syndrome. Pediatr Crit Care Med 2014; 15: 486-8.
13. Wakil SM, Monies DM, Abouelhoda M, Al-Tassan N, Al-Dusery H, Naim EA, et al., Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2015; 67: 288-95.
14. Romberg N, Al Moussawi K, Nelson-Williams C, Stiegler AL, Loring E, Choi M, et al., Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 2014; 46: 1135-9.
15. Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al., An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 2014; 46: 1140-6.